INS and diabetes mellitus: Recently, GLP1-RAs, a new anti-diabetic drug class causing insulin secretion through pancreatic cell stimulation, have been shown to prevent the development of diabetes in pre-diabetic subjects, to lower Hb1Ac and, importantly, to reduce gastric emptying and therefore encourage weight loss [142].